Curated industry list

High-Beta Momentum in Biotechnology on NASDAQ

Explore High-Beta Momentum in Biotechnology on NASDAQ. Compare qualifying stocks using fair value, valuation, financial quality, analyst expectations, and market data.

Cue Biopharma (CUE)
Fair Value26.8% Upside Undervalued Analyst184.8% Upside Market Cap224.5 M P/E Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Momentum
Rhythm Pharmaceuticals Inc (RYTM)
Fair Value-2.4% Downside Fair Analyst39.6% Upside Market Cap6.835 B P/E Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Momentum
Spyre Therapeutics Inc (SYRE)
Fair Value-43.8% Downside Overvalued Analyst30.6% Upside Market Cap8.109 B P/E Yield0.0% HealthGood
  NASDAQ Featured in High-Beta Momentum
Summit Therapeutics PLC (SMMT)
Fair Value-3.1% Downside Fair Analyst68.1% Upside Market Cap13.657 B P/E Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Momentum Bullish Trend Stocks
Compass Pathways Plc (CMPS)
Fair Value-4.3% Downside Fair Analyst60.7% Upside Market Cap2.047 B P/E Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Momentum
Exagen Inc (XGN)
Fair Value-43.7% Downside Overvalued Analyst12.8% Upside Market Cap211.7 M P/E Yield0.0% HealthGood
  NASDAQ Featured in High-Momentum Stocks High-Beta Momentum
Korro Bio Inc (KRRO)
Fair Value17.7% Upside Fair Analyst95.4% Upside Market Cap152.3 M P/E Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Momentum
TriSalus Life Sciences Inc (TLSI)
Fair Value7.1% Upside Fair Analyst106.9% Upside Market Cap303.6 M P/E Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Momentum
Twist Bioscience Corp (TWST)
Fair Value-50.7% Downside Expensive Analyst-33.4% Downside Market Cap10.322 B P/E Yield0.0% HealthGood
  NASDAQ Featured in High-Momentum Stocks High-Beta Momentum
Adlai Nortye Ltd ADR (ANL)
Fair Value-33.4% Downside Overvalued Analyst77.7% Upside Market Cap1.069 B P/E Yield0.0% HealthFair
  NASDAQ Featured in High-Momentum Stocks High-Beta Momentum High-Growth Small-Cap Stocks
Caris Life Sciences Inc (CAI)
Fair Value-24.2% Downside Overvalued Analyst-10.5% Downside Market Cap8.893 B P/E82.4x Yield0.0% HealthGreat
  NASDAQ Featured in High-Momentum Stocks High-Beta Momentum
Citius Oncology Inc (CTOR)
Fair Value42.2% Upside Undervalued Analyst273.8% Upside Market Cap113.2 M P/E Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Momentum Bullish Trend Stocks
Sagimet Biosciences Inc (SGMT)
Fair Value-36.8% Downside Overvalued Analyst166.9% Upside Market Cap689.3 M P/E Yield0.0% HealthGood
  NASDAQ Featured in High-Momentum Stocks High-Beta Momentum
Satellos Bioscience Inc (MSLE)
Fair Value-4.6% Downside Fair Analyst195.9% Upside Market Cap191.3 M P/E Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Momentum
Explore listed stocks on NASDAQ with company information and fair value data.